Check out

Monday, November 24, 2025

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

from NYT > Health https://ift.tt/4UdYxmK

No comments:

Post a Comment

New PEPFAR Data Show Worrying Declines in Testing and Treatment for H.I.V.

The numbers are the first to quantify the effect of the Trump administration’s shutdown and restarting of a program that has saved millions ...